Page 70 - Read Online

Page 16 of 21 Dokko et al. Vessel Plus 2022;6:37 https://dx.doi.org/10.20517/2574-1209.2021.121

17. Bando K, Kasegawa H, Okada Y, et al. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral
valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005;129:1032-40. DOI PubMed
18. Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia
control. J Am Coll Cardiol 2011;58:1474-81. DOI PubMed
19. Borger MA, Mansour MC, Levine RA. Atrial fibrillation and mitral valve prolapse: time to intervene? J Am Coll Cardiol
2019;73:275-7. DOI PubMed PMC
20. Gertz ZM, Raina A, Mountantonakis SE, et al. The impact of mitral regurgitation on patients undergoing catheter ablation of atrial
fibrillation. Europace 2011;13:1127-32. DOI PubMed
21. Lombard FW, Liang Y. Risk factors for mitral valve surgery: atrial fibrillation and pulmonary hypertension. Semin Cardiothorac
Vasc Anesth 2019;23:57-69. DOI PubMed
22. Zarse M, Deharo JC, Mast F, Allessie MA. Importance of right and left atrial dilation and linear ablation for perpetuation of sustained
atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:164-71. DOI PubMed
23. Fan K, Lee KL, Chow WH, Chau E, Lau CP. Internal cardioversion of chronic atrial fibrillation during percutaneous mitral
commissurotomy: insight into reversal of chronic stretch-induced atrial remodeling. Circulation 2002;105:2746-52. DOI PubMed
24. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial
fibrillation. Circulation 1976;53:273-9. DOI PubMed
25. Parkash R, Green MS, Kerr CR, et al; Canadian Registry of Atrial Fibrillation. The association of left atrial size and occurrence of
atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004;148:649-54. DOI
PubMed
26. Zacà V, Galderisi M, Mondillo S, Focardi M, Ballo P, Guerrini F. Left atrial enlargement as a predictor of recurrences in lone
paroxysmal atrial fibrillation. Can J Cardiol 2007;23:869-72. DOI PubMed PMC
27. John B, Stiles MK, Kuklik P, et al. Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J
2008;29:2234-43. DOI PubMed
28. Lau DH, Linz D, Sanders P. New findings in atrial fibrillation mechanisms. Card Electrophysiol Clin 2019;11:563-71. DOI PubMed
29. Iung B, Leenhardt A, Extramiana F. Management of atrial fibrillation in patients with rheumatic mitral stenosis. Heart
2018;104:1062-8. DOI PubMed
30. Candan O, Gecmen C, Kalayci A, Dogan C, Bayam E, Ozkan M. Left atrial electromechanical conduction time predicts atrial
fibrillation in patients with mitral stenosis: a 5-year follow-up speckle-tracking echocardiography study. Int J Cardiovasc Imaging
2017;33:1491-501. DOI PubMed
31. John B, Lau CP. Atrial fibrillation in valvular heart disease. Card Electrophysiol Clin 2021;13:113-22. DOI PubMed
32. Harada A, Sasaki K, Fukushima T, et al. Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve
disease. Ann Thorac Surg 1996;61:104-12. DOI PubMed
33. Gammie JS, Chikwe J, Badhwar V, et al. Isolated mitral valve surgery: the society of thoracic surgeons adult cardiac surgery database
analysis. Ann Thorac Surg 2018;106:716-27. DOI PubMed
34. McCarthy PM, Davidson CJ, Kruse J, et al. Prevalence of atrial fibrillation before cardiac surgery and factors associated with
concomitant ablation. J Thorac Cardiovasc Surg 2020;159:2245-53.e15. DOI PubMed
35. Kim JY, Kim SH, Myong JP, et al. Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
Heart 2020;106:746-50. DOI PubMed PMC
36. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease:
executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical
Practice Guidelines. Circulation 2021;143:e35-71. DOI PubMed
37. January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice
Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol
2014;64:e1-76. DOI PubMed
38. Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart 2020;106:10-7. DOI PubMed PMC
39. Hindricks G, Potpara T, Dagres N, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of
atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force
for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special
contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373-498. DOI PubMed
40. Beller JP, Krebs ED, Hawkins RB, et al. Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing. J Thorac
Cardiovasc Surg 2020;160:1222-31. DOI PubMed PMC
41. Nathan AS, Yang L, Geng Z, et al. Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair. Am Heart J
2021;232:1-9. DOI PubMed
42. Malik AH, Yandrapalli S, Aronow WS, Panza JA, Cooper HA. Oral anticoagulants in atrial fibrillation with valvular heart disease
and bioprosthetic heart valves. Heart 2019;105:1432-6. DOI PubMed
43. Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of non-vitamin K antagonist oral anticoagulants versus
warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis. J Am Heart Assoc
2017;6:e005835. DOI PubMed PMC